Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This report describes two patients with alopecia universalis, onychodystrophy, and vitiligo, and found no underlying systemic or etiological causes through extensive investigations.

In this study, vitiligo and alopecia areata were more common among patients with chronic graft-vs-host disease than previously reported, linked to higher NIH skin scores and greater immunosuppressive treatment.

Alopecia areata is relatively common in children, has a variable course, and shows different responses to treatment; thyroid testing is recommended for those affected.

The document explains how to claim CME credit by diagnosing and treating hair loss conditions in two patient cases.

Light therapy can effectively treat vitiligo and hair loss caused by a specific medication.

This case report observed complete repigmentation of a stable vitiligo patch with body hair transplantation in a 28-year-old man, with no recurrence after 3 months.

In this case study, treatment with the selective JAK1 inhibitor upadacitinib significantly improved symptoms in a patient with refractory alopecia areata, vitiligo, ankylosing spondylitis, and allergic asthma-nasal syndrome, though a transient liver function abnormality was noted.

This study found that platelet-rich plasma is effective and safe for treating chronic wounds, particularly diabetic and venous ulcers, and vitiligo, without increasing the risk of infection.

This case study identified a 22-year-old patient with multiple autoimmune syndrome type 3, involving lupus erythematosus, autoimmune thyroiditis, alopecia areata, and vitiligo.

This study provides evidence-based recommendations for the off-label use of topical vitamin D in treating certain skin conditions, but highlights the need for higher quality studies for further validation.

This meta-analysis found that patients with alopecia areata have significantly higher odds of also having immune-mediated diseases such as atopic dermatitis, autoimmune thyroiditis, inflammatory bowel disease, systemic lupus erythematosus, and vitiligo, suggesting a need for comprehensive screening and interdisciplinary management.

This study observed that while the number of patients receiving phototherapy in a Taiwanese hospital returned to pre-COVID-19 levels after a temporary closure, only about 40% of previous patients resumed treatment, indicating a significant impact of the pandemic on phototherapy services.

This study found that during the COVID-19 pandemic, the incidence of stress-related dermatologic diseases increased, despite overall reduced clinic visits, suggesting dermatologists should be more aware of these conditions.

This study found that patients with vitiligo commonly had facial involvement and associated autoimmune thyroid disease, highlighting the importance of monitoring thyroid antibodies and regular follow-up.

This study found that nail abnormalities, particularly longitudinal ridging, were more frequent in vitiligo patients (78%) compared to healthy controls (55%).

This study reported successful repigmentation without scarring in patients with localized and segmental vitiligo after epidermal grafting, but the Koebner phenomenon hindered similar results in some with generalized vitiligo.

This study found that a combined pattern of repigmentation was most commonly observed in vitiligo, with a new 'medium spotted' pattern proposed for areas with few hair follicles.

This study found that fractional Er:YAG laser combined with platelet-rich plasma resulted in greater skin repigmentation in patients with localized stable vitiligo compared to microneedling with platelet-rich plasma, with fewer side effects reported in the laser group.

This letter discusses a case of Hepatitis C-related vitiligo in a patient with Ivemark syndrome and presents no new clinical results.

In this study involving 13 patients with vitiligo-associated leukotrichia, minimal hair repigmentation was observed following treatment with fractional CO₂ laser and topical betamethasone, though the method was well tolerated, highlighting the need for further research to optimize treatment parameters.

In this study, plasmatherapy was found to improve immune status indicators in patients with vitiligo, particularly benefiting those with segmental vitiligo by normalizing immune markers and reducing IL-6 levels, suggesting its potential as an adjunct treatment to slow depigmentation progression.

This paper discusses the need for a standardized classification and meta-analysis of treatments for hypopigmented disorders and reports no new clinical results.

This study suggests that combining baricitinib with narrowband UV-B therapy is an effective and well-tolerated approach for treating active nonsegmental vitiligo.

Manage vitiligo with treatments, address emotions, and use camouflage techniques.

This case study reported significant but temporary hair regrowth and skin repigmentation in a patient with vitiligo and alopecia areata during treatment with oral ruxolitinib.

This abstract contains no research results; it provides information about the JAMA Dermatology journal and its access options.

Vitiligo causes white skin patches and is linked to autoimmune issues.

This article discusses the need for a personalized and stratified therapeutic approach for vitiligo, utilizing current knowledge and expertise, but it does not report new clinical results.

This study reported a case where cyclosporine treatment in a child led to remission of ulcerative colitis and regrowth of scalp and body hair, suggesting a possible connection between the disorders.

An 8-year-old girl with vitiligo developed extra hair growth on her knee after using tacrolimus ointment.